Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopaminergic neurons are specialized nerve cells that synthesize and release dopamine, a key neurotransmitter in the central nervous system. These neurons are relatively few in number—about 400,000 in the human brain—but have widespread influence due to their extensive axonal projections. Their cell bodies are primarily located in specific midbrain regions: the substantia nigra pars compacta (SNpc), ventral tegmental area (VTA), and retrorubral field. Dopaminergic neurons regulate voluntary movement, motivation, reward associations, habit learning, cognitive functions, and mood regulation. Loss or dysfunction of these neurons is central to several neurological diseases, including Parkinson’s Disease and neuropsychiatric disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopaminergic Neuron (DA Neuron).